Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Impact of NOciception Level (NOL) Index Intraoperative Guidance of REmifentanil Administration on Opioid Consumption and QoR in Ambulatory Patients Undergoing LAparoscopic Cholecystectomy. A Randomized Controlled Trial"

NCT07810894 is registered in ClinicalTrials.gov with Svendborg Hospital as lead sponsor.

NCT NCT07810894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07810894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Impact of NOciception Level (NOL) Index Intraoperative Guidance of REmifentanil Administration on Opioid Consumption and QoR in Ambulatory Patients Undergoing LAparoscopic Cholecystectomy. A Randomized Controlled Trial"
Lead sponsor
Svendborg Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2023
Completion date
September 30, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elective laparoscopic cholecystectomy